ST8814-parental-vs-resistant_MSigDB_Hallmark_down.png

syn66496873

Created By Sasha Scott Sasha.scott

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

ST8814-parental-vs-resistant_MSigDB_Hallmark_down.png page is loading…